Craft

Asymchem

Stock Price

¥84.3

2024-10-29

Market Capitalization

¥30.5 B

2024-10-29

Revenue

¥5.7 B

FY, 2024

Asymchem Summary

Company Summary

Overview
Asymchem Laboratories (Tianjin) (凯莱英医药集团 (天津) 股份有限公司) is a company engaged in contract research, development, and manufacturing of pharmaceutical products. It offers drug development, preclinical research, formulation study, cell culture process development, clone screening, pilot production, etc. The company also provides IP protection, supply chain management, quality assurance, and other services.
Type
Public
Status
Active
Founded
1999
HQ
Tianjin, CN | view all locations
Website
https://www.asymchem.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • James Gage

    James Gage, Chief Science Officer

    • Hao Hong

      Hao Hong, CEO, Chairman

      • Rui Yang

        Rui Yang, Chief Operating Officer

        • Da Zhang

          Da Zhang, Chief Financial Officer

          LocationsView all

          10 locations detected

          • Tianjin, Tianjin Shi HQ

            China

            6 Dongting 3rd St, Binhai Xinqu

          • Morrisville, NC

            United States

            600 Airport Blvd #1000

          • Shanghai Shi

            China

            2888 Caolang Hwy, Jinshan Qu

          • Beijing Shi

            China

            a - 504, no, 9 Dongdaqiao Rd, Chaoyang Qu

          • Tianjin Shi

            China

            Guotai Bridge, Tai'erzhuang Rd, Hexi Qu

          • Shanghai Shi

            China

            Guo Zhan Lu, Pudong Xinqu

          and 4 others

          Asymchem Financials

          Summary Financials

          Revenue (Q1, 2025)
          ¥1.5B
          Gross profit (Q1, 2025)
          ¥643.4M
          Net income (Q1, 2025)
          ¥324.6M
          Cash (Q1, 2025)
          ¥6.8B
          EBIT (Q1, 2025)
          ¥302.0M
          Enterprise value
          $24.0B

          Footer menu